Summary:
A Study of Excess Fat in the Liver @ Wake Research Associates
Wake Research Associates is currently enrolling volunteers in a research study of the safety and effectiveness of an investigational drug for excess fat in the liver (NASH*). *Nonalcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver.
Qualified Participants Must:
Have NASH or your doctor suspects that you have NASH
Be are overweight
Have type 2 diabetes, or are pre-diabetic
Be between 18 and 75 years of age
Qualified Participants May Receive:
Study-related drug, Study-related medical exams, and Compensation up to $1800 for time and travel.